Ebit Cambiamento Data
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Cytokinetics USD -167.09M 12.08M 2026-09
Daiichi Sankyo JPY 108.7B 23.6B 2026-09
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Gilead Sciences USD 3.85B 1.17B 2026-06
Incyte USD -707.47M 1.41B 2026-09
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Novartis USD 5.14B 411M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
TG Therapeutics USD 21.67M 13.12M 2026-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09
Xencor USD -36.6M 41.26M 2026-06